Catalent Pharma Solutions has announced that it will invest $20 million to enhance pMDI clinical and commercial supply capabilities, along with other enhancements, at its Inhalation Center of Excellence in Research Triangle Park (RTP), North Carolina. The company offers a range of development and manufacturing services for inhaled products and says that it also … [Read more...] about Catalent to invest $20 million to expand inhalation capabilities
Business
MVIC announces new member, date for next symposium
Lars Borgström Consulting has joined the Medicon Valley Inhalation Consortium (MVIC), bringing the group of companies involved in inhalation product development in the Skåne-Copenhagen region to 14 members. Borgström, the first recipient of RDD's Charles G. Thiel award, recently retired from AstraZeneca and is offering "advice on clinical aspects of inhaled medication … [Read more...] about MVIC announces new member, date for next symposium
Asthmapolis named a finalist for Bluetooth Breakthrough Awards
The Bluetooth Special Interest Group (SIG) has named Asthmapolis a finalist in the "Breakthrough Products" category for the Bluetooth Breakthrough Awards. The FDA granted 510(k) clearance to the Asthmapolis inhaler sensor system and mobile app in July 2012. When attached to the top of an MDI canister, the sensor records accelerometer and GPS data, which it transmits … [Read more...] about Asthmapolis named a finalist for Bluetooth Breakthrough Awards
Prosonix gets grant for development of multi-component particle inhaled drugs
The Biomedical Catalyst, a joint program of the UK's Medical Research Council and the Technology Strategy Board, has awarded a grant of up to £1.3M in matched funding to Prosonix for support of a research consortium focused on pre-clinical development of the Prosonix Multi-Component Particle (MCP) platform for excipient-free inhaled combination drugs. The consortium … [Read more...] about Prosonix gets grant for development of multi-component particle inhaled drugs
Teva Pro-Air MDI with dose counter now available in US
Teva Respiratory says that the ProAir HFA metered dose inhaler with dose counter for the treatment of asthma is now available. The albuterol MDI with dose counter was approved by the FDA in March 2012. At the time, the company announced that the new inhaler would be available by the end of 2012. Teva says that it needed time to manufacture a sufficient inventory to … [Read more...] about Teva Pro-Air MDI with dose counter now available in US
Mitsubishi to acquire Qualicaps
The Carlyle group has agreed to sell Mitsubishi Chemical Holdings Corporation all outstanding shares of pharmaceutical capsule manufacturer Qualicaps. Products manufactured by Qualicaps include both gelatin and hypromellose capsules for use with dry powder inhalers. Mitsubishi will pay approximately ¥55.8 billion, or about $660 million, for the company. Read … [Read more...] about Mitsubishi to acquire Qualicaps
Discovery Labs launches Afectair system
Discovery Laboratories has announce the launch of its Afectair airway connector for the delivery of aerosolized medications to infants in neonatal or pediatric intensive care units. The disposable device enables delivery of aerosolized drugs to patients on ventilatory support at the patient interface and was initially developed in conjunction with the company's … [Read more...] about Discovery Labs launches Afectair system
Acorda plans to submit 505(b)(2) NDA for diazepam nasal spray
Acorda Therapeutics says that it has completed its acquisition of Neuronex, including Neuronex's diazepam nasal spray formulation, for $6.8 million. The company also announced that it plans to submit a 505(b)(2) NDA in 2013 for the diazepam nasal spray as a treatment for seizures in epilepsy patients. In early 2012, Acorda paid $2 million to Neuronex as an option … [Read more...] about Acorda plans to submit 505(b)(2) NDA for diazepam nasal spray
Matrixx Initiatives recalls single lot of Zicam nasal spray
Matrixx Initiatives has voluntarily recalled a single lot of Zicam Extreme Congestion Relief nasal gel spray due to contamination with Burkholderia cepacia in a single sample. Zicam is a homeopathic product available over the counter in the US. The affected lot, which was distributed to retailers throughout the US, is number 2J23. The 0.5 oz spray bottles are … [Read more...] about Matrixx Initiatives recalls single lot of Zicam nasal spray
SkyePharma gets $8 million settlement from AstraZeneca for Pulmicort deal termination
SkyePharma has announced that AstraZeneca will pay $8 million in January 2013 "to settle certain disputes" resulting from AZ's termination of their licensing deal for the Pulmicort MDI. The deal was terminated after AZ discontinued production of the inhaler in early 2011 due to manufacturing problems. At the time, SkyePharma, which developed the product, said that … [Read more...] about SkyePharma gets $8 million settlement from AstraZeneca for Pulmicort deal termination